Public health
fromArs Technica
3 weeks agoFDA refuses to review Moderna's mRNA flu vaccine
FDA refused to review Moderna's application for mRNA-1010, citing trial comparator design despite prior FDA acceptance and trial showing superiority over standard-dose influenza vaccines.